Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$77.4M Sell
1,265,531
-6,308
-0.5% -$384K 1.33% 20
2017
Q1
$77.1M Sell
1,271,839
-20,852
-2% -$1.27M 1.38% 15
2016
Q4
$72.6M Buy
1,292,691
+185,667
+17% +$10.9M 1.42% 16
2016
Q3
$65.9M Buy
1,107,024
+145,832
+15% +$8.53M 1.24% 25
2016
Q2
$52.8M Sell
961,192
-64,913
-6% -$3.45M 1.04% 30
2016
Q1
$51.8M Buy
1,026,105
+504,476
+97% +$24.7M 1.04% 31
2015
Q4
$26.3M Buy
521,629
+23,559
+5% +$1.19M 0.51% 63
2015
Q3
$23.5M Buy
498,070
+473,608
+1,936% +$25.2M 0.47% 66
2015
Q2
$1.33M Buy
24,462
+305
+1% +$17.1K 0.02% 264
2015
Q1
$1.32M Sell
24,157
-617
-2% -$34.9K 0.02% 256
2014
Q4
$1.34M Sell
24,774
-965
-4% -$53.8K 0.03% 251
2014
Q3
$1.46M Buy
25,739
+510
+2% +$28.6K 0.03% 243
2014
Q2
$1.39M Buy
25,229
+3,265
+15% +$178K 0.03% 261
2014
Q1
$1.19M Buy
21,964
+3,434
+19% +$178K 0.02% 276
2013
Q4
$885K Buy
18,530
+4,455
+32% +$204K 0.02% 267
2013
Q3
$639K Sell
14,075
-2,165
-13% -$98.8K 0.01% 303
2013
Q2
$720K Buy
+16,240
New +$725K 0.02% 246

Other funds holding MRK

Geneva Advisors's MRK Position: Q2 2017 in Review

Geneva Advisors reduced its Merck (MRK) stake by 0.5% in Q2 2017, selling an estimated $384K and leaving 1,265,531 shares worth $77.4M. The position accounts for 1.33% of the portfolio, ranked #20.

Geneva Advisors first reported a position in MRK in Q2 2013 and has held it in 17 quarters since. 1,925 funds tracked by Wall St. Rank hold MRK as of Q2 2017.

  • Geneva Advisors held 1,265,531 shares of Merck worth $77.4M as of Q2 2017.
  • Geneva Advisors sold 6,308 Merck shares in Q2 2017, an estimated $384K.
  • Merck made up 1.33% of Geneva Advisors's portfolio in Q2 2017, its #20 holding.
  • Geneva Advisors first reported a position in Merck in Q2 2013 and has held it in 17 quarters since.
  • 1,925 funds tracked by Wall St. Rank held Merck as of Q2 2017.

Based on Geneva Advisors's 13F filing for Q2 2017, filed 7 Aug 2017.